FTC Fights Nixing Of AndroGel Reverse Payment Suit
By Erin Marie Daly · June 10, 2010, 7:06 PM EDT
The Federal Trade Commission is challenging the dismissal of its claims accusing Solvay Pharmaceuticals Inc. of paying generic-drug makers not to compete with its testosterone supplement AndroGel, continuing the fight over...
To view the full article, register now.